Cutaneous melanoma is an aggressive malignancy responsible for 90% of skin cancer-related mortality.
1 Although surgery is effective for early stages of disease, resections for locoregionally advanced melanoma often result in suboptimal outcomes. Patients with locoregional disease have the option to get intralesional therapy in addition to systemic therapy, which may augment responses, including recruitment of cells from circulation into the tumor(s).
2 …